Table 1.
Clinicopathologic characteristics in colorectal carcinoma n (%)
| Variables | WMDA | PDA | MUA | SRCC | |
| (n = 63) | (n = 91) | (n = 81) | (n = 15) | ||
| Gender | Male | 39 (61.9) | 45 (49.5) | 46 (56.8) | 6 (40.0) |
| Female | 24 (38.1) | 46 (50.5) | 35 (43.2) | 9 (60.0) | |
| Age (yr) | Range | 32-87 | 35-92 | 26-90 | 30-82 |
| Median | 65 | 64 | 71 | 70 | |
| Family history of CRC | Yes | 5 (7.9) | 5 (6.1) | 5 (6.3) | 2 (13.3) |
| No | 58 (92.1) | 77 (93.9) | 75 (93.7) | 13 (86.7) | |
| Unknown | 9 | 1 | |||
| Location | Left-sided | 43 (68.3) | 38 (41.8) | 40 (49.4) | 6 (40.0) |
| Right-sided | 20 (31.7) | 53 (58.2) | 41 (50.6) | 9 (60.0) | |
| Depth | Up tp MP | 10 (15.9) | 4 (4.4) | 5 (6.2) | 1 (6.7) |
| Beyond MP | 53 (84.1) | 87 (95.6) | 76 (93.8) | 14 (93.3) | |
| Venous invasion | Yes | 48 (76.2) | 77 (85.6) | 41 (50.6) | 14 (93.3) |
| No | 15 (23.8) | 13 (14.4) | 40 (49.4) | 1 (6.7) | |
| Unknown | 1 | ||||
| Lymphatic invasion | Yes | 35 (55.6) | 82 (91.1) | 54 (66.7) | 12 (80.0) |
| No | 28 (44.4) | 8 (8.9) | 27 (33.3) | 3 (20.0) | |
| Unknown | 1 | ||||
| Nodal metastasis | Yes | 34 (54.0) | 69 (78.4) | 37 (46.8) | 9 (64.3) |
| No | 29 (46.0) | 19 (21.6) | 42 (53.2) | 5 (35.7) | |
| Unknown | 3 | 2 | 1 | ||
| Chemotherapy | Yes | 17 (27.0) | 42 (53.8) | 31 (41.9) | 7 (46.7) |
| No | 46 (73.0) | 36 (46.2) | 43 (58.1) | 8 (53.3) | |
| Unknown | 13 | 7 | |||
| Irradiation | Yes | 4 (6.3) | 2 (2.6) | 3 (4.1) | 1 (7.1) |
| No | 59 (93.7) | 76 (97.4) | 71 (95.9) | 14 (92.9) | |
| Unknown | 13 | 7 | |||
| TNM stage | I/II | 29 (46.0) | 17 (18.9) | 40 (50.0) | 4 (26.7) |
| III/IV | 34 (54.0) | 73 (81.1) | 40 (50.0) | 11 (73.3) | |
| Unknown | 1 | 1 | 0 |
CRC: Colorectal carcinoma; WMDA: Well-to-moderately differentiated adenocarcinoma; PDA: Poorly differentiated adenocarcinoma; MUA: Mucinous adenocarcinoma; SRCC: Signet-ring cell carcinoma; MP: Muscularis propria; TNM: Tumor node metastasis.